These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 474944)

  • 1. Central dopamine receptors regulate blood eosinophilia in the rat.
    Podolec Z; Vetulani J; Bednarczyk B; Szczeklik A
    Allergy; 1979 Apr; 34(2):103-10. PubMed ID: 474944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A; Kehr W; Lindqvist M
    J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
    Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.
    Reches A; Wagner HR; Jackson-Lewis V; Fahn S
    Brain Res; 1985 Nov; 347(2):346-9. PubMed ID: 3933764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
    Strömbom U; Svensson TH; Carlsson A
    Psychopharmacology (Berl); 1977 Mar; 51(3):293-9. PubMed ID: 403547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in mice.
    Watanabe H
    J Pharmacol Methods; 1985 Aug; 14(1):41-7. PubMed ID: 3928976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
    Fisher A; Biggs CS; Eradiri O; Starr MS
    Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor in the reward system of the rat.
    Kadzielawa K
    Arch Int Pharmacodyn Ther; 1974 Jun; 209(2):214-26. PubMed ID: 4441165
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
    Reches A; Wagner HR; Jiang D; Jackson V; Fahn S
    Life Sci; 1982 Jul; 31(1):37-44. PubMed ID: 7109853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):111-7. PubMed ID: 193050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum.
    Lopez A; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Neuroscience; 2001; 103(3):639-51. PubMed ID: 11274784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.